YES1 is an SFK and is frequently amplified and overexpressed in various human malignancies, including lung, breast, ovarian, and skin cancers [32], and has been increasingly recognized for its role in promoting cell proliferation, survival, invasiveness, and chemoresistance [31,61]. The gene discussed is YES1; the disease is skin neoplasm.